Affiliation:
1. Section of Hospital Hygiene, Department of Medical Microbiology and Hygiene, Ulm University Hospital
2. Clinical Pharmacy
3. Microbiological Laboratory, Klinikum Memmingen, Memmingen, Germany
4. Institute of Biometry and Medical Documentation, University of Ulm, Ulm
Abstract
ABSTRACT
It is generally assumed that the antibiotic prescription policy of a hospital has a significant impact on bacterial resistance rates; however, few studies are available to support this concept with valid statistical data. During a 3-year period from 1997 to 2000, we monitored the consumption of β-lactam and other antibiotics with known activity against
Pseudomonas aeruginosa
in a 600-bed community hospital. Monthly isolations of
P. aeruginosa
were assessed, and resistance rates were recorded. Partial correlation coefficients between consumption and resistance rates were determined, taking into account possible associations with other variables such as seasonal effects and transfers from other hospitals. A total of 30 ± 7 novel
P. aeruginosa
strains per month were isolated without epidemic clustering. Prescriptions of imipenem varied significantly during the study period, while prescriptions of other antipseudomonal agents were stable, with the exception of an increase in piperacillin-tazobactam prescriptions. Rates of resistance of
P. aeruginosa
to the antimicrobial agents used showed a time course similar to figures for imipenem consumption. Monthly rates of resistance to imipenem (partial correlation coefficient [cc], 0.63), piperacillin-tazobactam (cc, 0.57), and ceftazidime (cc, 0.56) were significantly associated with imipenem prescription rates in the same or the preceding month, while consumption of ceftazidime or piperacillin-tazobactam had no apparent association with resistance. Among the variables investigated, imipenem consumption was identified as the major factor associated with both carbapenem and β-lactam resistance in endemic
P. aeruginosa
. Periods of extensive imipenem use were associated with significant increases in resistance. Our data support the concept that a written antibiotic policy which balances the use of various antibiotic classes may help to avoid disturbances of a hospital's microbial sensitivity patterns.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference27 articles.
1. Carmeli, Y., N. Troillet, A. W. Karchmer, and M. H. Samore. 1999. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch. Intern. Med.159:1127-1132.
2. Emergence of Antibiotic-Resistant
Pseudomonas aeruginosa
: Comparison of Risks Associated with Different Antipseudomonal Agents
3. Chatzinikolaou, I., D. Abi-Said, G. P. Bodey, K. V. Rolston, J. J. Tarrand, and G. Samonis. 2000. Recent experience with Pseudomonasaeruginosa bacteremia in patients with cancer: retrospective analysis of 245 episodes. Arch. Intern. Med.160:501-509.
4. Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients
5. Deutsches Institut für Normung e.V. 2000. Methods for antibiotic susceptibility testing of bacterial pathogens p. 1-11. DIN 58940-4 attachment 1. Beuth Verlag Berlin Germany.
Cited by
125 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献